Bayer Intends to Divest Blood Plasma Business

摘要

BAYER AG plans to shed its plasma business,but will hold onto the Kogenate product line.The Research Triangle park,N.C-based business,part of Bayer's Biological Products division,had sales of euro679 million (us794 million)in 2002.